1. Stocks
  2. ARS Pharmaceuticals Inc
  3. Swot
swot-logo

ARS Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

ARS Pharmaceuticals Inc has 17 Strengths, 7 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Stock gained more than 20% in one month

Book Value per share Improving for last 2 years

RSI indicating price strength

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

PEG greater than Industry PEG

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Top Losers

Top Losers

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks